Skip navigation
HKU Login
Guest Login
Home
Publications
Researchers
Staff
Research Postgraduates
Organizations
Grants
Datasets
Deposit Data
HKUL Research Data Management
Theses
Patents
Community Service
Browsing by Author Cheng, PNM
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
中
or enter first few letters:
Showing results 1 to 13 of 13
Title
Author(s)
Issue Date
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients
Journal:
Investigational New Drugs
Yau, TCC
Cheng, PNM
Chiu, WYJ
Kwok, GW
Leung, RCY
Liu, AM
Cheung, TT
Ng, CT
2021
Anti-tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma
Journal:
Current Cancer Drug Targets
Chow, AKM
Ng, L
Li, HS
Cheng, CW
Lam, CSC
Yau, TCC
Cheng, PNM
Fan, ST
Poon, RTP
Pang, RWC
2012
Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial-mesenchymal transition
Journal:
Scientific Reports
XU, S
Lam, SK
Cheng, PNM
Ho, JCM
2019
der(Y)t(Y;1) is a nonrandom abnormality in myelodysplastic syndrome [4]
Journal:
Cancer Genetics and Cytogenetics
Wei, DCC
Wan, TSK
Chan, LC
Cheng, PNM
1993
Endogenous arginase 2 as a biomarker for PEGylated arginase 1 treatment in squamous cell lung carcinoma xenograft models
Proceeding/Conference:
Journal of Clinical Oncology
Ho, JCM
Xu, S
Cheng, PNM
Lam, SK
2018
In vitro effects of pegylated arginase in small cell lung cancer
Proceeding/Conference:
Journal of Thoracic Oncology
Xu, S
Lam, SK
Cheng, PNM
Ho, JCM
2016
Inhibition of ornithine decarboxylase facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models
Proceeding/Conference:
Journal of Thoracic Oncology
Ho, JCM
U, KP
Xu, S
Cheng, PNM
Lam, SK
2017
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells
Journal:
Oxidative Medicine and Cellular Longevity
Zhao, Z
Zhang, P
Li, W
Wang, D
Ke, C
Liu, Y
Ho, JCM
Cheng, PNM
XU, S
Editor(s):
Quiles, JL
2021
Pegylated recombinant human hepatic arginase I (rhArg-peg 5,000 mw) inhibits human hepatocellular carcinoma in vitro and in vivo
Proceeding/Conference:
The International Meeting of Hepatocellular Carcinoma
Cheng, PNM
Lo, T
Leung, T
Poon, RTP
2004
Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
Journal:
Cancer Letters
Lam, TL
Wong, GKY
Chong, HC
Cheng, PNM
Choi, SC
Chow, TL
Kwok, SY
Poon, RTP
Wheatley, DN
Lo, WH
Leung, YC
2009
Remission of hepatocellular carcinoma with Arginine depletion induced by systemic release of endogenous hepatic arginase due to transheaptic embolization augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma
Proceeding/Conference:
The International Meeting of Hepatocellular Carcinoma
Cheng, PNM
Leung, T
Lo, T
Poon, RTP
2004
Remission of hepatocellular carcinoma with Arginine depletion induced by systemic release of endogenous hepatic arginase due to transheaptic embolization augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma (
Journal:
Asian Journal of Surgery
Cheng, PNM
Leung, T
Lo, T
Poon, RTP
2005
Suppression of tumour growth by pegylated arginase in malignant pleural mesothelioma
Proceeding/Conference:
Journal of Thoracic Oncology
Ho, JCM
U, KP
Xu, S
Cheng, PNM
Lam, SK
2017